TAR
IGC icon

Trask Adam Roland’s IGC Pharma IGC Stock Holding History

Trask Adam Roland’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31K Buy
+5,000
New +$1.39K ﹤0.01% 187

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Trask Adam Roland's IGC Position: Q1 2026 in Review

Trask Adam Roland opened a new position in IGC Pharma (IGC) in Q1 2026: 5,000 shares worth $1.31K. The stake represents ﹤0.01% of the portfolio and ranks #187 among its holdings.

35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

  • Trask Adam Roland held 5,000 shares of IGC Pharma worth $1.31K as of Q1 2026.
  • IGC Pharma was a new Trask Adam Roland position in Q1 2026.
  • IGC Pharma made up ﹤0.01% of Trask Adam Roland's portfolio in Q1 2026, its #187 holding.
  • 35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Trask Adam Roland's 13F filing for Q1 2026, filed 15 May 2026.